Literature DB >> 17168149

Invasive fungal sinusitis caused by Pseudallescheria boydii: case report and literature review.

Dwight D Bates1, J Whitman Mims.   

Abstract

Fungal sinusitis secondary to Pseudallescheria boydii is rare, as only 25 cases have been previously reported in the literature. Although Pboydii resembles Aspergillus on pathologic examination, it is typically resistant to amphotericin B. Therefore, culture is necessary to differentiate the two. Patients with P boydii sinusitis should generally be treated with a combination of surgery and antifungal therapy. Combination treatment is particularly important for immunocompromised patients with fungal invasion because mortality among these patients is high. The prognosis is better for immunocompetent patients, even those with fungal invasion. We describe a new case of invasive fungal sinusitis secondary to P. boydii infection, and we review the literature on this emerging pathogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168149

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  Pseudallescheria fusoidea, a new cause of osteomyelitis.

Authors:  Mark D Lindsley; Josep Guarro; Raed N Khairy; JoaAnna Williams; Naureen Iqbal; Preeti Pancholi
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

2.  Successful prevention of scedosporiosis after lung transplantation in a cystic fibrosis patient by combined local and systemic triazole therapy.

Authors:  Carolin Hartmann; Carsten Müller; Hartmut Weißbrodt; Sebastian Suerbaum; Kathrin Tintelnot; Stefan Stolle; Gesine Hansen; Ludwig Sedlacek
Journal:  Med Mycol Case Rep       Date:  2013-05-23

3.  Successful Treatment of Scedosporium Sinusitis in Two Lung Transplant Recipients: Review of the Literature and Recommendations for Management.

Authors:  Elisabeth H Ference; Bernard M Kubak; Paul Zhang; Jeffrey D Suh
Journal:  Allergy Rhinol (Providence)       Date:  2019-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.